---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-032503"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2025-08-25T23:59:59+00:00"
generated_at: "2026-05-17T10:12:18.290162+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# PDS Biotechnology files routine corporate presentation update; no material new information disclosed

## Summary
- Company updated its investor presentation deck on August 25, 2025 (Exhibit 99.1).
- The filing contains no new financial results, clinical data, or guidance changes.
- Presentation covers previously announced precision oncology pipeline, no new milestones.
- No material events such as earnings, M&A, regulatory actions, or leadership changes.

## SEC filing metadata
- accession: 0001140361-25-032503
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2025-08-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036125032503/0001140361-25-032503-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036125032503/ef20054434_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-032503
- JSON: https://secwatch.observer/filing/0001140361-25-032503.json
- Plain text: https://secwatch.observer/filing/0001140361-25-032503.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.